New genetically based score could help identify young children at high risk of impulsive behavior

While not all impulsive behavior speaks of mental illness, a wide range of mental health disorders which often emerge in adolescence, including depression and substance abuse, have been linked to impulsivity. So, finding a way to identify and treat those who may be particularly vulnerable to impulsivity early in life is especially important.

A group of researchers, led by scholars at McGill University, have developed a genetically based score which could help identify, with a high degree of accuracy (greater than that of any impulsivity scores currently in use), the young children who are most at risk of impulsive behavior.

Their findings are especially compelling because the score they have developed was able to detect those at a higher risk of impulsivity within three ethnically diverse community samples of children, from a cohort of close to 6,000 children.

This discovery of a novel score for impulsivity in early life can inform prevention strategies and programs for children and adolescents who are at risk for psychiatric disorders. In addition, by describing the function of the gene networks comprising the score, the study can stimulate the development of new therapies in the future.

A shift in perspective leads to new findings

The impulsivity risk score was developed by looking at the co-expression of a number of genes in the prefrontal cortex and the striatum, areas of the brain that play a role in decision-making and emotional regulation, among other things.

"Typically, genetic approaches to identifying the neurobiological signature for impulsivity (or any other condition or disease) tend to focus on identifying the variation in a few genetic markers that might be responsible for the problem," said Patricia Pelufo Silveira, an Associate Professor in the Department of Psychiatry and Researcher at the Douglas Research Centre and one of the two senior authors on the recent paper in Molecular Psychiatry. "We came at the problem from the opposite direction, by focusing on a gene known to be associated with the maturation of the brain in these two key areas and then looking for a network of other genes that were most closely associated with it."

It took a lot of hunting

This approach was based on earlier work in mice models, led by Cecilia Flores, a co-senior author on the paper and a Full Professor, in the Department of Psychiatry which had identified the importance of a specific gene (known as DCC), which acts as a "guidance cue" that determines when and precisely where brain dopamine cells form connections in the prefrontal cortex and striatum. This coordinated development is essential for the maturation of impulse control.

But to create the new impulsivity score, it took a lot of hunting to narrow down the genes most closely associated with DCC.

Our approach exploits the fact that genes operate within complex networks that, ultimately, perform very precise biological functions. These so-called gene networks have the property of being highly tissue-specific, so we began with an unbiased look at groups of genes that are co-expressed with DCC in brain regions known to play an important role supporting inhibitory control."

Jose Maria Restrepo, Co-Author, PhD Student, Integrated Program in Neuroscience, McGill University

"The results underline the importance of data sharing and open science", adds Flores. "Imagine if we had had to collect this information in all these countries over all these years. Our discovery was only possible because we had access to all these data."

Source:
Journal reference:

Restrepo-Lozano, J.M., et al. (2022) Corticolimbic DCC gene co-expression networks as predictors of impulsivity in children. Molecular Psychiatry. doi.org/10.1038/s41380-022-01533-7.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Evo model set to transform synthetic biology and disease diagnosis